CNS tumors

CNS tumors working group

Promotes studies and networks to strengthen neuro-oncology in Switzerland.

Ongoing Studies

PHENIX

EORTC-LEGATO

Treatment of patients with glioblastoma with lomustine and radiotherapy or lomustine without radiotherapy when the disease progresses for the first time - a randomized phase III trial (LEGATO)

SAKK 70/24 PHENIX

Phase II study to evaluate the efficacy of the combination of trimipramine and atezolizumab with bevacizumab in patients with recurrent glioblastoma. PHENIX (SAKK 70/24)

CNS tumors working group

Activities and successes
The group is actively involved in the establishment of a Swiss glioma network. A database with clinical and imaging data and a virtual tumor biobank is to realize scientific projects in the field of neuro-oncology in Switzerland.

The working group aims to develop new, innovative clinical studies in order to further strengthen and expand collaboration between the various neuro-oncology centers in Switzerland. In the longer term, the working group aims to achieve the status of a project group.

Emilie Le Rhun

Vice President Central Nervous System Tumors

+41 44 255 29 92 emilie.lerhun@usz.ch
Philippe Schucht

Leitender Arzt, Leiter Lehre und Forschung

+41 31 632 80 64 philippe.schucht@insel.ch